Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
Wei JIA public CV
View Scopus Profile
Wei JIA, Prof
Visiting Chair Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0002-3739-8994
Email
weijia1
hkbu.edu
hk
2009
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(3)
Research Output
(135)
Prizes / Awards
(5)
Activities
(23)
Press/Media
(4)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Wei JIA is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Bile Acids
87%
Gut Microbiota
67%
Gut Microbiome
28%
Non-alcoholic Fatty Liver Disease (NAFLD)
28%
Hepatocellular Carcinoma
28%
Metabolomics
27%
Lipid Metabolism
22%
Bile Acid Metabolism
22%
Metabolic Profiling
20%
Targeted Proteomics
19%
Inflammation
18%
Bile Acid Profile
17%
Colorectal Cancer
17%
Theabrownin
15%
Mouse Model
15%
Ursodeoxycholic Acid
15%
Hyodeoxycholic Acid
15%
Chronic Liver Disease
13%
Liver Fibrosis
13%
Microbiome
13%
Primary Bile Acid
13%
Glycine
13%
Alcoholic Liver Disease
13%
Liver
13%
Serum Bile Acids
12%
Gut Metabolites
12%
Pu-erh Tea
12%
Host Metabolism
12%
Gut Microbiota Metabolism
12%
Microbial Metabolites
11%
Chenodeoxycholic Acid
11%
Metabolism
11%
Secondary Bile Acids
11%
Baijiu
10%
Genome Analysis
10%
Nonalcoholic Steatohepatitis
10%
Farnesoid X Receptor
10%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
10%
Microbiota
9%
Fructose
9%
Chinese Patients
9%
Traditional Chinese Medicine
9%
Serum Metabolomics
9%
Hydroxylated
9%
Irritable Bowel Syndrome
9%
Deoxycholate
9%
Metabolic Signature
9%
Multiple Myeloma
9%
Peroxisome Proliferator-activated Receptor
9%
Gut Microbial Community
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Intestine Flora
47%
Nonalcoholic Fatty Liver
35%
Biological Marker
25%
Microbiome
23%
Inflammation
17%
Diseases
16%
Fibrosis
15%
Liver Fibrosis
15%
Ursodeoxycholic Acid
14%
Microflora
13%
Deoxycholic Acid
13%
Hyodeoxycholic Acid
13%
Carcinogenesis
12%
Chronic Liver Disease
12%
Fatty Acid
12%
Polysaccharide
11%
Chronic Hepatitis B
11%
Peroxisome Proliferator Activated Receptor
11%
Liver Cell Carcinoma
11%
Colorectal Carcinoma
10%
Malignant Neoplasm
9%
Irritable Colon
9%
Chenodeoxycholic Acid
9%
CYP3A
8%
Mouse Model
8%
Liver Injury
8%
Farnesoid X Receptor
8%
Fructose
8%
Astragalus
7%
Toxicokinetics
7%
Liver Cirrhosis
7%
Bile Acid Conjugate
7%
Cholic Acid
7%
Ethanol
7%
Receptor
7%
Non Insulin Dependent Diabetes Mellitus
7%
Liver Disease
6%
Microorganism
6%
Amino Acid
6%
Taurodeoxycholic Acid
6%
Hepatitis B Virus
6%
Fatty Liver
5%
Serine
5%
Tryptophan
5%
Abdominal Cancer
5%
Traditional Chinese Medicine
5%
Metabolic Syndrome X
5%
Psoriasis
5%
Taurocholic Acid
5%
Medicine and Dentistry
Gut Microbiota
47%
Bile Acid
45%
Gut
24%
Colorectal Carcinoma
20%
Metabolite
20%
Nonalcoholic Fatty Liver
18%
Liver Fibrosis
15%
Hepatocellular Carcinoma
14%
Microbiome
13%
Metabolome
13%
Fibrosis
12%
Diagnosis
12%
Carcinogenesis
11%
Gut Microbiome
11%
Metabolomics
11%
Receptor
10%
Diseases
9%
Lipid Metabolism
9%
Traditional Chinese Medicine
9%
Malignant Neoplasm
9%
Homeostasis
8%
COVID-19
7%
Chronic Hepatitis B
7%
Clinical Study
7%
Patient with Type 2 Diabetes
7%
Bile
7%
Astragalus
7%
Cardiorespiratory
7%
Homeopathy
7%
Caloric Restriction
7%
Multiple Myeloma
7%
Insulin Release
7%
AMP-Activated Protein Kinase
7%
1,5-Anhydroglucitol
7%
Chronic Liver Disease
7%
Metabolic Disorder
7%
High Fat Food
7%
Bile Acid Metabolism
7%
Fructose
7%
Fatty Liver
7%
Diabetes
7%
Probiotics
6%
Non-Alcoholic Fatty Liver Disease
6%
Polysaccharide
6%
Blood Glucose
6%
Maturity Onset Diabetes of the Young
6%
Liver Disease
5%
Neonatal Infant
5%
Liver Cirrhosis
5%
Insulin Sensitivity
5%